NYSE International 100
10.933,92
PKT
-33,65
PKT
-0,31
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE International 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.03.21 | Allianz buy | Deutsche Bank AG | |
| 29.03.21 | Mercedes-Benz Group (ex Daimler) overweight | JP Morgan Chase & Co. | |
| 29.03.21 | Allianz overweight | JP Morgan Chase & Co. | |
| 29.03.21 | Siemens overweight | JP Morgan Chase & Co. | |
| 29.03.21 | Mercedes-Benz Group (ex Daimler) buy | Jefferies & Company Inc. | |
| 26.03.21 | Unilever buy | Jefferies & Company Inc. | |
| 26.03.21 | Philips buy | UBS AG | |
| 26.03.21 | Diageo buy | UBS AG | |
| 26.03.21 | AstraZeneca buy | UBS AG | |
| 25.03.21 | Philips Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.03.21 | Diageo buy | Jefferies & Company Inc. | |
| 25.03.21 | Telefonica Hold | Kepler Cheuvreux | |
| 25.03.21 | AXA overweight | JP Morgan Chase & Co. | |
| 25.03.21 | Diageo buy | UBS AG | |
| 25.03.21 | SAP Outperform | Credit Suisse Group | |
| 25.03.21 | UBS Outperform | Credit Suisse Group | |
| 25.03.21 | Nokia Equal weight | Barclays Capital | |
| 24.03.21 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 24.03.21 | AXA Outperform | RBC Capital Markets | |
| 24.03.21 | Diageo Outperform | Credit Suisse Group | |
| 23.03.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 23.03.21 | Novartis buy | Jefferies & Company Inc. | |
| 23.03.21 | Mercedes-Benz Group (ex Daimler) kaufen | DZ BANK | |
| 23.03.21 | Novartis market-perform | Bernstein Research | |
| 23.03.21 | Deutsche Telekom Outperform | Credit Suisse Group | |
| 23.03.21 | Unilever Sell | UBS AG | |
| 23.03.21 | UBS kaufen | DZ BANK | |
| 23.03.21 | AstraZeneca buy | UBS AG | |
| 23.03.21 | Unilever buy | Deutsche Bank AG | |
| 23.03.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.03.21 | Philips overweight | Barclays Capital | |
| 23.03.21 | Santander Neutral | JP Morgan Chase & Co. | |
| 22.03.21 | Unilever buy | Goldman Sachs Group Inc. | |
| 22.03.21 | AstraZeneca overweight | Barclays Capital | |
| 22.03.21 | Deutsche Telekom Equal weight | Barclays Capital | |
| 22.03.21 | Novartis market-perform | Bernstein Research | |
| 22.03.21 | HSBC Neutral | UBS AG | |
| 22.03.21 | Barclays buy | UBS AG | |
| 22.03.21 | ING Group buy | UBS AG | |
| 22.03.21 | AstraZeneca Sell | Goldman Sachs Group Inc. |